Abstract |
The effect of CMNQ was studied on mitochondria isolated from S-180 ascites tumor cells. It was found that the primary metabolic event upon addition of CMNQ to S-180 mitochondria was a stimulation of oxygen uptake. The oxygen utilization rate was maximized at about 50 nmoles CMNQ/mg protein; at doses higher than this, inhibition of respiration was observed relative to the stimulation of respiration produced by CCCP. It was also up to 50 nmoles CMNQ/mg protein. S-180 ATPase activity is stimulated maximally by 125 nmoles CMNQ/mg protein; at doses higher than this, slight inhibition of the ATPase activity relative to the stimulation produced by CCCP is seen. In vivo treatment of CMNQ to tumor bearing animals leads to a significant reduction of in vitro S-180 cellular respiration rates. The data presented in this work coupled with previously published reports involving CMNQ support the proposal for a mitochondrial level of action for this bioreductive alkylating antineoplastic agent.
|
Authors | R E Biagini, R S Pardini, A J Lin, A C Sartorelli |
Journal | Cancer biochemistry biophysics
(Cancer Biochem Biophys)
Vol. 3
Issue 3
Pg. 129-34
( 1979)
ISSN: 0305-7232 [Print] England |
PMID | 162226
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Naphthoquinones
- Succinates
- 2,3-bis(chloromethyl)-1,4-naphthoquinone
- Carbonyl Cyanide m-Chlorophenyl Hydrazone
- Adenosine Diphosphate
- Adenosine Triphosphatases
|
Topics |
- Adenosine Diphosphate
(metabolism)
- Adenosine Triphosphatases
(metabolism)
- Animals
- Carbonyl Cyanide m-Chlorophenyl Hydrazone
(pharmacology)
- Kinetics
- Mice
- Mitochondria
(drug effects, metabolism)
- Naphthoquinones
(pharmacology)
- Oxidative Phosphorylation
(drug effects)
- Oxygen Consumption
(drug effects)
- Sarcoma 180
(metabolism)
- Succinates
(metabolism)
|